Molecular modeling of human APOBEC3G to predict the binding modes of the inhibitor compounds IMB26 and IMB35
APOBEC3G(A3G) is a host cytidine deaminase that incorporates into HIV-1 virions and efficiently inhibits viral replication. The virally encoded protein Vif binds to A3G and induces its degradation, thereby counteracting the antiviral activity of A3G. Vif-mediated A3G degradation clearly represents a...
Main Authors: | Zhixin Zhang, Congjie Zhai, Zeyun Mi, Jiwei Ding, Yongxin Zhang, Xing Shi, Xiaoyu Li, Liyan Yu, Zhuorong Li, Jiandong Jiang, Jinming Zhou, Shan Cen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-07-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383513000415 |
Similar Items
-
Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
by: Maria Yousefi, et al.
Published: (2023-02-01) -
Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids
by: Jin Hu, et al.
Published: (2022-12-01) -
APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA
by: Shreoshri Bhattacharjee, et al.
Published: (2024-01-01) -
Polymorphisms in Human APOBEC3H Differentially Regulate Ubiquitination and Antiviral Activity
by: Nicholas M. Chesarino, et al.
Published: (2020-03-01) -
Identification and characterization of loop7 motif and its role in regulating biological function of human APOBEC3G through molecular modeling and biological assay
by: Congjie Zhai, et al.
Published: (2017-09-01)